WallStreetZenWallStreetZen

NASDAQ: GCTK
Glucotrack Inc Stock Ownership - Who owns Glucotrack?

Insider buying vs selling

Have Glucotrack Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GCTK insiders and whales buy or sell their stock.

GCTK Shareholders

What type of owners hold Glucotrack Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Boston Financial Mangement LLC0.17%26,372$32.70kInstitution
Allen Danzig0.10%15,048$18.66kInsider
Alerus Financial Na0.07%11,500$14.26kInstitution
Rockefeller Capital Management LP0.00%200$248.00Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

GCTK vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GCTK0.25%0.10%
LUCY2.85%67.36%
EKSO6.12%93.88%Net SellingNet Selling
NURO3.71%96.29%Net Buying
STSS2.65%38.35%Net Buying

Glucotrack Stock Ownership FAQ

Who owns Glucotrack?

Glucotrack (NASDAQ: GCTK) is owned by 0.25% institutional shareholders, 0.10% Glucotrack insiders, and 99.66% retail investors. Allen Danzig is the largest individual Glucotrack shareholder, owning 15,048.00 shares representing 0.10% of the company. Allen Danzig's Glucotrack shares are currently valued at $18.66k.

If you're new to stock investing, here's how to buy Glucotrack stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.